Controlled Release Drug Delivery Market Size, Share, Analysis, Trends, Growth Report, 2030

Controlled Release Drug Delivery Market

Controlled Release Drug Delivery Market By Technology (Targeted Delivery, Transdermal, Implants, Microencapsulation, Coacervation, Wurster Technique, and Others), By Release Mechanism (Activation-Modulated Drug Delivery Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Chemically Activated, Feedback Regulated Drug Delivery Systems, and Polymer-Based Systems), By Application (Drug-Eluting Stents, Infusion Pumps, Oral Controlled-Drug Delivery Systems, Injectable, Transdermal & Ocular Patches, and Metered Dose Inhalers): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-5835 Published Date: Feb-2021 Status : Published
Market Size in 2019 Market Forecast in 2026 CAGR (in %) Base Year
USD 36.49 Billion USD 59.36 Billion 7.4% 2019

Controlled Release Drug Delivery Market

Controlled Release Drug Delivery Industry Perspective:

The controlled-release drug delivery market is set for rapid growth over the forecast period. In terms of revenue, the global automated sortation system market accounted for USD 36.49 Billion in 2019 and is expected to reach USD 59.36 Billion by 2026, growing at a CAGR of 7.4% from 2020 to 2026.

The report analyzes the global controlled-release drug delivery market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the controlled-release drug delivery industry.       

Global Controlled Release Drug Delivery Market: Overview

Controlled-release drug delivery is a dosage form that delivers medication in a predetermined way. It is a mechanism that facilitates continuous drug delivery in reproducible kinetics for a fixed time throughout the gastrointestinal transit course. It keeps on releasing the drug dosages until it reaches the predetermined region in the gastrointestinal tract. There are several benefits of such a drug delivery system like higher bioavailability, enhanced patient compliance, efficacy, improved drug safety, minimum side effects, lower dose requirement, and improved stability of the drug.

Global Controlled Release Drug Delivery Market: Growth Factors

The growing preference of medical professionals for controlled-release drugs coupled with the changing prescription patterns over traditional drug delivery systems is driving the growth of the global controlled-release drug delivery market significantly. Moreover, being a highly fragmented and competitive market, the major market players are proactive with the transforming requirements and are increasingly investing in innovating and developing more advanced drugs to drive the global controlled release drug delivery market vigorously.

The growing research and development activities to develop efficient therapy for non-communicable and chronic diseases like hypertension, diabetes, and cancer are fueling the growth of the market globally. The constantly growing pediatric and geriatric population is boosting the market growth significantly owing to the non-adherence to the medical routine. The geriatric population suffers from biological, mental, and physical malfunction that affects medical intake. Their body is not able to tolerate the optimum dosages and ill effects of drugs and hence it fuels the demand for the controllable release drug delivery system.

Global Controlled Release Drug Delivery MarketRequest Free Sample

Global Controlled Release Drug Delivery Market: Segmentation

The global controlled-release drug delivery market can be segmented into technology, application, release mechanism outlook, and region.

By technology, the market can be segmented into targeted delivery, transdermal, implants, microencapsulation, coacervation, Wurster technique, and others. Targeted delivery accounts for the largest share in the global controlled release drug delivery market due to its added advantages it aids in permitting drugs to stay away from the area or region that might cause drug toxicity and facilities required site of action.

By release mechanism outlook, the market can be segmented into activation-modulated drug delivery systems, micro reservoir partition controlled drug delivery systems, chemically activated, feedback-regulated drug delivery systems, and polymer-based systems. The feedback-regulated drug delivery systems segment dominates the global market due to its high therapeutic efficiency in treating various diseases.

By application, the market can be segmented into drug-eluting stents, infusion pumps, oral controlled-drug delivery systems, injectable, transdermal & ocular patches, and metered dose inhalers. The oral controlled-drug delivery systems hold hegemony over others owing to their frequent uses and wide availability.

Controlled Release Drug Delivery Market: Report Scope

Report Attributes Report Details
Report Name Controlled Release Drug Delivery Market Research Report
Market Size in 2019 USD 36.49 Billion
Market Forecast in 2026 USD 59.36 Billion
Growth Rate CAGR of 7.4%
Number of Pages 255
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered APOLLO RT Co. Ltd., Sino Medical-Device Technology Co., Ltd., VIVID IMAGING, GE Healthcare, Nemoto Kyorindo Co., Ltd., Ulrich GmbH & Co. KG, Bayer HealthCare LLC, Medtronic AG, Guerbet Group, Bracco Group, Capsugel, Aradigm Corporation, Pfizer, Inc, Depomed, Inc., Corium International, Inc., Coating Place, Inc., Johnson and Johnson, Alkermes plc, Merck and Co., Inc., F. Hoffman-La-Roche Ltd., Sanofi, Mylan N.V., GlaxoSmithKline plc, Vectura Group plc, Sun Pharmaceuticals Industries Ltd, Abbott Laboratories, Bristol-Myers Squibb Company, and Orbis Biosciences, Inc., among others.
Segments Covered By Components, By Deployment, By Organization Size, By Application, By Verticals, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Base Year 2019
Historical Year 2016 to 2019
Forecast Year 2020 - 2026
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Controlled Release Drug Delivery Market: Regional Analysis

North America accounts for the largest share in the global controlled release drug delivery market owing to the growing supportive initiatives from the government for the developments of the regional market. Moreover, the surging research and development activities are anticipated to propel regional market growth.

Europe is expected to witness huge growth due to the presence of prominent market players in the region coupled with the increasing incidences of patients suffering from chronic illnesses like diabetes, cancer, chronic obstructive pulmonary disease (COPD), and many others.

Asia Pacific is a potential region in the global controlled release drug delivery market and is likely to grow significantly during the forecast period owing to the growing development of healthcare infrastructure and the surging geriatric population in the region.

Global Controlled Release Drug Delivery Market: Competitive Players

Some of the major players in the global controlled-release drug delivery market are

  • APOLLO RT Co. Ltd.
  • Sino Medical-Device Technology Co.
  • Ltd.
  • VIVID IMAGING
  • GE Healthcare
  • Nemoto Kyorindo Co.Ltd.
  • Ulrich GmbH & Co. KG
  • Bayer HealthCare LLC
  • Medtronic AG
  • Guerbet Group
  • Bracco Group
  • Capsugel
  • Aradigm Corporation
  • Pfizer.Inc
  • Depomed.Inc.
  • Corium International.Inc.
  • Coating Place.Inc.
  • Johnson and Johnson
  • Alkermes plc
  • Merck and Co.Inc.
  • F. Hoffman-La-Roche Ltd.
  • Sanofi
  • Mylan N.V.
  • GlaxoSmithKline plc
  • Vectura Group plc
  • Sun Pharmaceuticals Industries Ltd
  • Abbott Laboratories
  • Bristol-Myers Squibb Company
  • and Orbis Biosciences.Inc.
  • among others.

The global controlled-release drug delivery market is segmented as follows:

By Technology

  • Targeted Delivery
  • Transdermal
  • Implants
  • Micro Encapsulation
  • Coacervation
  • Wurster Technique
  • Others

By Release Mechanism

  • Activation-modulated Drug Delivery Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Chemically Activated
  • Feedback Regulated Drug Delivery Systems
  • Polymer-Based Systems

By Application

  • Drug-Eluting Stents
  • Infusion Pumps
  • Oral Controlled-Drug Delivery Systems
  • Injectable
  • Transdermal and Ocular Patches
  • Metered Dose Inhalers

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

The global controlled release drug delivery market was valued at USD 36.49 Billion in 2019.

The global controlled release drug delivery market is expected to reach USD 59.36 Million by 2026, growing at a CAGR of 7.4% between 2020 to 2026.

The growing preference of the medical professionals for the controlled-release drug coupled with the changing prescription patterns over traditional drug delivery systems is driving the growth of the global controlled release drug delivery market significantly. Moreover, being a highly fragmented and competitive market, the major market players are pro-active with the transforming requirements and are increasingly investing in innovating and developing more advanced drugs to drive the global controlled release drug delivery market vigorously.

North America accounts for the largest share in the global controlled release drug delivery market owing to the growing supportive initiatives from the government for the developments of the regional market. Moreover, the surging research and development activities are anticipated to propel the regional market growth.

Some of the major companies operating in the controlled release drug delivery market are APOLLO RT Co. Ltd., Sino Medical-Device Technology Co., Ltd., VIVID IMAGING, GE Healthcare, Nemoto Kyorindo Co., Ltd., Ulrich GmbH & Co. KG, Bayer HealthCare LLC, Medtronic AG, Guerbet Group, Bracco Group, Capsugel, Aradigm Corporation, Pfizer, Inc, Depomed, Inc., among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed